Value Aligned Research Advisors, LLC
"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.
13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.
We backtested copying it. Buying this fund's new positions the day each filing went public, over 10 quarters, returned +16.4% per quarter versus +4.4% from owning every 13F stock, beating that baseline in 80.0% of quarters (excess t = 3.68, statistically significant). Caveat: across all 5,072 funds we tested, past performance shows near-zero persistence (rank correlation −0.018) — with thousands of funds, some will look significant by chance alone.
Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)
Top 20 holdings of 53 · 2026 Q1
| Ticker | Value | Weight | QoQ |
|---|---|---|---|
| LITE | $743M | | TRIM |
| CRWV | $642M | | ADD |
| BE | $621M | | ADD |
| NBIS | $603M | | ADD |
| VRT | $486M | | TRIM |
| CLS | $420M | | ADD |
| STX | $358M | | ADD |
| WDC | $350M | | NEW |
| COHR | $306M | | TRIM |
| FIX | $295M | | ADD |
| EQT | $267M | | ADD |
| FTAI | $262M | | NEW |
| FCX | $260M | | NEW |
| AMAT | $250M | | ADD |
| LRCX | $235M | | ADD |
| KLAC | $211M | | ADD |
| EME | $165M | | ADD |
| IREN | $163M | | ADD |
| APLD | $158M | | ADD |
| NVDA | $149M | | ADD |
QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.
New positions in 2026 Q1
Method & Limitations
Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.